Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J builds case for ketamine-based depression drug
J&J builds case for ketamine-based depression drug
J&J builds case for ketamine-based depression drug
Submitted by
admin
on January 3, 2018 - 10:07am
Source:
Biopharma Dive
News Tags:
JNJ
esketamine
ketamine
clinical depression
Headline:
J&J builds case for ketamine-based depression drug
Do Not Allow Advertisers to Use My Personal information
